Braiin (NASDAQ:BRAI) Raised to Hold at Zacks Research

Braiin (NASDAQ:BRAIGet Free Report) was upgraded by research analysts at Zacks Research to a “hold” rating in a research note issued on Tuesday,Zacks.com reports.

BRAI has been the subject of a number of other reports. Wall Street Zen upgraded Braiin from a “sell” rating to a “hold” rating in a report on Sunday, May 31st. Maxim Group assumed coverage on Braiin in a report on Monday. They issued a “buy” rating and a $10.00 target price for the company. Finally, Weiss Ratings assumed coverage on Braiin in a report on Wednesday, May 6th. They issued a “sell (e+)” rating for the company. One equities research analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $10.00.

Read Our Latest Stock Report on Braiin

Braiin Stock Up 25.0%

NASDAQ:BRAI opened at $9.36 on Tuesday. The company has a fifty day moving average of $7.86. Braiin has a 12-month low of $4.19 and a 12-month high of $33.00.

More Braiin News

Here are the key news stories impacting Braiin this week:

  • Positive Sentiment: Braiin announced a landmark Australian contract with BillCentral Pty Ltd to deploy its full-stack Agentic AI customer experience platform, a meaningful win that could help validate demand for its CXaaS offering and support international expansion. Article Title
  • Positive Sentiment: Maxim Group reiterated a Buy rating on Braiin and set a $10 price target, while forecasting a path from near-term losses to profitability by FY2027-FY2028. That kind of analyst support can help investor confidence. Article Title
  • Neutral Sentiment: Several other headlines about brain activity, memory, autism, sleep, and related medical research are not directly tied to Braiin Ltd’s business and are unlikely to be a major driver of the stock today.

Braiin Company Profile

(Get Free Report)

Braiin Limited is an Australian technology company leveraging proprietary intellectual property and patented artificial intelligence/machine learning (“AI/ML”) technologies to deliver actionable insights across high-growth verticals: Agriculture, Property Technology, and Customer Experience as a Service (“CXaaS”). Our platforms are designed to address inefficiencies and drive data-backed decision-making across traditionally analog sectors. Our first commercial focus is on the agriculture technology sector, where we have successfully deployed our AI-powered solutions across multiple implementations.

Read More

Receive News & Ratings for Braiin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Braiin and related companies with MarketBeat.com's FREE daily email newsletter.